Sharemaestro Newsreel

Why QuidelOrtho (QDEL) Stock Is Nosediving

Why QuidelOrtho (QDEL) Stock Is Nosediving What Happened? Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 21.3% in the afternoon session after the company slashed its full-year revenue and earnings forecast, overshadowing a second-quarter earnings beat. For the second quarter, QuidelOrtho reported revenue of …

Why iRhythm (IRTC) Stock Is Trading Up Today

Why iRhythm (IRTC) Stock Is Trading Up Today What Happened? Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 2% in the afternoon session after the company reported strong second-quarter financial results that surpassed expectations and raised its full-year guidance. The cardiac monitoring company …

Tactile Systems Technology (TCMD) Beats Q2 Earnings and Revenue Estimates

Ceribell forecasts FY 2026 revenue of $114 million-$117 million

Ceribell has issued a revenue guidance for FY 2026, projecting $114 million-$117 million. The company reported a 33% year-over-year revenue increase in Q2 2026 and a year-to-date gross margin of 90% as of June 30, 2026. Ceribell estimates a U.S. market opportunity of $3.5 …

Earnings call transcript: Ceribell tops revenue growth in Q2 2026, shares rise

Ceribell reported strong Q2 2026 results, with revenue growing 33% year-over-year to $28.1 million, surpassing expectations despite an EPS miss. The medical-device company's shares rose as investors focused on its continued expansion in seizure detection, record gross margins of 92%, and advancement of new …

Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

In the latest close session, Medtronic (MDT) was up +2.58% at $89.41. The stock outperformed the S&P 500, which registered a daily loss of 0.06%. Elsewhere, the Dow lost 0.11%, while the tech-heavy Nasdaq lost 0.32%. The medical device company's stock has climbed by …

Tenon Medical (TNON) launches 1-for-35 reverse stock split to lift share price

Tenon Medical (TNON) has enacted a 1-for-35 reverse stock split, effective August 10, 2026, to increase its share price and meet Nasdaq's minimum listing requirement of $1.00. Each 35 shares of common stock were combined into one, with fractional shares rounded up. The stock …

Teledyne to acquire Varex Imaging in $1.1 billion deal

Teledyne Technologies announced its agreement to acquire Varex Imaging Corporation for approximately $1.1 billion. This acquisition will significantly expand Teledyne's medical and industrial X-ray imaging portfolio by adding Varex's X-ray tubes, digital X-ray detectors, and advanced photon-counting detectors. The deal, representing an 88% premium …

Earnings call transcript: TELA Bio misses Q2 2026 estimates, withdraws guidance

TELA Bio reported a significant miss on its Q2 2026 earnings, with both revenue and adjusted EPS falling short of Wall Street estimates. The company withdrew its full-year 2026 revenue guidance, citing slower sales-force productivity and weakness in its plastic and reconstructive surgery (PRS) …

Insulet Corp. stock underperforms Monday when compared to competitors despite daily gains

Insulet Corp. (PODD) stock saw a daily gain of 1.19% on Monday, closing at $142.85. Despite this increase, the stock underperformed against a general market downturn, with both the S&P 500 Index and Dow Jones Industrial Average recording slight declines. This marked the third …

Varex Imaging downgraded to Neutral from Buy at B. Riley

B. Riley downgraded Varex Imaging (VREX) to Neutral from Buy, increasing the price target slightly to $18.90 from $18.00. This change comes after Varex Imaging agreed to be acquired by Teledyne Technologies for $18.90 per share in cash, leaving limited upside potential without a …

Envoy Medical (NASDAQ: COCH) raises cash, advances fully implanted cochlear implant

Envoy Medical (NASDAQ: COCH) reported its Q2 2026 financial results, including a net loss of $7.3 million and net revenue of $51,000. The company significantly increased its cash position to $19.7 million from $3.7 million at year-end 2025, supported by $30 million in equity …

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones

Envoy Medical reported its second quarter 2026 financial results, highlighting significant progress in its corporate initiatives, particularly with its investigational Acclaim® cochlear implant. The company submitted the first module of its modular PMA application to the FDA and announced positive 12-month data from its …

Alamar Biosciences expands proteomics partnership by 86,000 samples

Alamar Biosciences is expanding its partnership with the Alzheimer’s Disease Data Initiative and Gates Ventures to analyze an additional 86,000 plasma samples using its NULISAseq Neuro 220 panel. This expansion builds on a previous initiative that profiled over 55,000 samples, aiming for a total …

Varex Imaging (VREX) swings to profit and plans $18.90-per-share sale to Teledyne

Ceribell (Nasdaq: CBLL) grows Q2 2026 revenue 33% but posts larger loss

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day

Edwards Lifesciences Corp. (EW) saw its stock advance by 2.57% to $92.03, outperforming the broader market during a grim trading session where the S&P 500 and Dow Jones Industrial Average both fell. This marks the third consecutive day of gains for the company's stock, …

Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?

Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 ⁠billion, above analysts' average estimate of about $25.05 billion. Adjusted earnings per share reached $2.90, surpassing the expectation of $2.85. The company also raised …

Boston Scientific Corp. stock outperforms competitors on strong trading day

Shares of Boston Scientific Corp. (BSX) rose 2.33% to $50.46 on Monday, outperforming the broader market which saw the S&P 500 Index and Dow Jones Industrial Average both decline. This marked the third consecutive day of gains for the stock.

Tactile Systems Technology (TCMD) Releases Q2 2026 Earnings: Revenue and EPS Beat Expectations

Form 8K Sight Sciences Inc For: 10 August By Investing.com

This article announces the filing of a Form 8K by Sight Sciences Inc. for August 10, 2026. It is a brief, standard financial news update provided by Investing.com, indicating a regulatory filing has occurred for the company.

QuidelOrtho partially recovers from earnings slide, rising 12% (QDEL:NASDAQ)

QuidelOrtho (QDEL) shares rebounded by nearly 12% after a two-session decline triggered by its Q2 earnings release. The company had initially fallen despite beating top and bottom-line estimates due to significant cuts in full-year revenue and EPS guidance and the withdrawal of free cash …

Stifel Nicolaus Lowers RxSight (NASDAQ:RXST) Price Target to $7.00

Stifel Nicolaus has reduced its price target for RxSight (NASDAQ:RXST) from $8.00 to $7.00, while maintaining a "hold" rating, suggesting an 11.82% potential upside. Despite the lowered target, RxSight recently reported better-than-expected quarterly results, surpassing analyst estimates for both earnings per share and revenue. …

MASS (MASS) investor Christopher Brown plans 100,000-share stock sale

Christopher Brown, an investor in MASS, has filed a Form 144 to sell 100,000 shares of MASS common stock, valued at $888,000.00. These shares were originally acquired as founder's shares and will be sold through Morgan Stanley Smith Barney LLC. The filing also notes …

Ceribell Reports Second Quarter 2026 Financial Results

Ceribell announced strong second-quarter 2026 financial results, with total revenue increasing 33% to $28.1 million driven by new account additions and increased utilization. The company also reported significant milestones, including multiple FDA 510(k) clearances for new algorithms and hardware designs, a new credit facility, …

Alamar: Q2 Earnings Snapshot

Alamar Biosciences Inc. (ALMR) reported a Q2 loss of $13.2 million, or 22 cents per share, which surpassed Wall Street expectations of a 36-cent loss. The biotech company, specializing in proteomics, posted revenue of $29.4 million for the period and projects full-year revenue between …

Tactile Systems Technology: Q2 Earnings Snapshot

Ceribell (CBLL) lifts 2026 outlook after 33% Q2 revenue growth to $28.1M

InspireMD Schedules 8:30 a.m. Call to Discuss Q2 Results

InspireMD (Nasdaq: NSPR) announced it will release its second quarter 2026 financial results on Monday, August 17, 2026. The company will host a conference call and live audio webcast at 8:30 a.m. Eastern Time to discuss the results and recent highlights. Investors can participate …

Delcath Systems resumes post-earnings momentum with 10% rally, sets new high (DCTH:NASDAQ)

Butterfly Network (BFLY) insider schedules sale of Class A stock after vesting

Butterfly Network insider Joseph M. Devivo has filed a Form 144 notice to sell 68,346 Class A shares of common stock. These shares are expected to vest from restricted stock on December 17, 2024, and will be sold through Fidelity Brokerage Services on the …

Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates

Orchestra BioMed Holdings, Inc. The BACKBEAT global pivotal trial ("BACKBEAT Trial"), conducted in collaboration with Medtronic, is on track to reach its target of 284 evaluable randomized patients by end of Q3 2026, with primary data presentation targeted for Q2 2027, assuming those endpoints …

Bioventus (BVS) Stock Still Looks Like A Bargain On Earnings

Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance

Alamar Biosciences reported strong second-quarter 2026 financial results, with total revenue increasing by 82% to $29.4 million and consumable revenue growing by nearly 150% year-over-year. The company also launched new products, including a multiplexed immunoassay for eMTBR-tau and the NULISAseq™ Immune 340 Panel, and …

Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures

Alamar Biosciences has expanded its partnership with the Alzheimer’s Disease Data Initiative and Gates Ventures to profile an additional 86,000 plasma samples using its NULISAseq™ Neuro 220 panel. This collaboration aims to create the largest neurodegenerative disease dataset, encompassing over 140,000 samples by 2027, …

Stryker Corp. stock underperforms Monday when compared to competitors despite daily gains

Stryker Corp. (SYK) shares increased by 2.00% to $345.81 on Monday, marking its fourth consecutive day of gains, despite an overall poor trading session for the broader market. The S&P 500 Index (SPX) fell 0.06% and the Dow Jones Industrial Average (DJIA) fell 0.11%. …